Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,919 | 646 | 98.1% |
| Education | $213.13 | 6 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,535 | 70 | $0 (2023) |
| Amgen Inc. | $1,325 | 79 | $0 (2024) |
| PFIZER INC. | $1,095 | 89 | $0 (2024) |
| ABBVIE INC. | $734.29 | 45 | $0 (2024) |
| Lilly USA, LLC | $689.46 | 39 | $0 (2024) |
| Genentech USA, Inc. | $572.30 | 36 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $545.89 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $512.79 | 17 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $478.71 | 46 | $0 (2020) |
| GlaxoSmithKline, LLC. | $472.85 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $490.35 | 18 | Octapharma USA, Inc. ($99.49) |
| 2023 | $2,056 | 81 | Amgen Inc. ($344.42) |
| 2022 | $377.33 | 17 | Janssen Biotech, Inc. ($92.54) |
| 2021 | $63.12 | 2 | AstraZeneca Pharmaceuticals LP ($43.43) |
| 2020 | $508.35 | 31 | Amgen Inc. ($95.30) |
| 2019 | $2,599 | 160 | Amgen Inc. ($316.59) |
| 2018 | $2,475 | 161 | Janssen Biotech, Inc. ($529.21) |
| 2017 | $2,562 | 182 | Janssen Biotech, Inc. ($426.87) |
All Payment Transactions
652 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $99.49 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Immunology | ||||||
| 02/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 02/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Dermatology | ||||||
| 02/12/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Inflammation | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.05 | General |
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 02/01/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Immunology | ||||||
| 01/29/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/25/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Rare Disease | ||||||
| 01/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CNS | ||||||
| 01/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Bone Health | ||||||
| 12/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Immunology | ||||||
| 12/05/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Bone Health | ||||||
| 11/29/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: KRYSTEXXA | ||||||
| 11/28/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Inflammation | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 843 | 10,107 | $830,989 | $168,544 |
| 2022 | 14 | 790 | 5,950 | $756,510 | $176,392 |
| 2021 | 15 | 939 | 14,408 | $1.4M | $287,165 |
| 2020 | 16 | 1,040 | 5,991 | $763,575 | $216,896 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 14 | 7,400 | $543,972 | $74,748 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 395 | $94,800 | $32,446 | 34.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,200 | $55,776 | $21,963 | 39.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 26 | 87 | $31,842 | $8,314 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $22,204 | $6,416 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 102 | $16,830 | $5,874 | 34.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 83 | $16,268 | $3,943 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,580 | $3,388 | 32.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 46 | $10,266 | $2,428 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $6,156 | $2,353 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,162 | $1,958 | 31.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 264 | $1,848 | $1,765 | 95.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 50 | $5,700 | $1,028 | 18.0% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 16 | 29 | $2,639 | $750.38 | 28.4% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 11 | 14 | $2,635 | $544.27 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 38 | $2,204 | $408.50 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 47 | 270 | $1,107 | $216.49 | 19.6% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 14 | 3,030 | $475,410 | $85,352 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 377 | $90,480 | $31,404 | 34.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,440 | $66,931 | $24,386 | 36.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 28 | 110 | $40,260 | $11,200 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $21,112 | $6,601 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 112 | $18,480 | $6,109 | 33.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 16 | 74 | $14,504 | $3,684 | 25.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 24 | 34 | $7,611 | $1,733 | 22.8% |
About Dr. Fernando Castro, MD
Dr. Fernando Castro, MD is a Internal Medicine healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518063718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Castro, MD has received a total of $11,132 in payments from pharmaceutical and medical device companies, with $490.35 received in 2024. These payments were reported across 652 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,919).
As a Medicare-enrolled provider, Castro has provided services to 3,612 Medicare beneficiaries, totaling 36,456 services with total Medicare billing of $848,997. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Rheumatology
- Location West Columbia, SC
- Active Since 09/15/2006
- Last Updated 10/15/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518063718
Products in Payments
- SIMPONI ARIA (Biological) $763.88
- XELJANZ (Drug) $702.54
- Enbrel (Biological) $671.88
- TALTZ (Drug) $582.44
- ORENCIA (Biological) $478.71
- BENLYSTA (Biological) $472.85
- STELARA (Biological) $462.06
- COSENTYX (Biological) $443.88
- Cimzia (Drug) $438.21
- Rituxan (Biological) $373.50
- Humira (Biological) $364.27
- KEVZARA (Biological) $318.72
- TREMFYA (Drug) $266.98
- RINVOQ (Biological) $252.95
- KEVZARA SARILUMAB INJECTION (Biological) $247.99
- EVENITY (Biological) $240.25
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $233.56
- SAPHNELO (Biological) $227.90
- INFLECTRA (Biological) $218.05
- Actemra (Biological) $198.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Columbia
Dr. Robert Leonardi, M.d, M.D
Internal Medicine — Payments: $229,082
Dr. Christopher Rowley, M.d, M.D
Internal Medicine — Payments: $15,552
Brian Wall, Md, Ms, MD, MS
Internal Medicine — Payments: $12,930
Dr. William Brabham, Md, MD
Internal Medicine — Payments: $10,911
Dr. Gayatri Kuraganti, M.d, M.D
Internal Medicine — Payments: $10,391
Matthew Thoma, Md, MD
Internal Medicine — Payments: $9,534